Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mupirocin vs Bivatracin spray for hemodialysis catheter infection
NCT05874219Phase 3Completed
- Sponsor
- Future University in Egypt
- Start
- Apr 2023
- Primary completion
- May 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of neomycin and Bacitracin Plus in Catheter-related infection (CRI) (2 arms), sponsored by Future University in Egypt. Primary endpoint: Catheter related infection at 45 days. Started Apr 2023; status: completed.
02
Drugs
neomycinBacitracin Plus
03
Conditions
Catheter-related infection (CRI)
Beyond the preview
Go deeper on NCT05874219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05874219.